Form D · Biotechnology
NeuroTherapeutics Pharma, Inc.
Chicago, IL · CIK 0001385386
Offering snapshot reported Dec 21, 2011 · SEC filing
- Reported sold
- $12M Offering amount: $47.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2011 | Initial | $12,000,000 | No comparison | 8 | SEC filing |
| May 28, 2010 | Initial | $18,511,530 | No comparison | 10 | SEC filing |
| Jan 6, 2009 | Initial | $3,200,000 | No comparison | Not reported | SEC filing |
| Dec 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170464
Source: Form D, filed Dec 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas R. Beck, M.D. | Director |
| Karen Boezi | Director |
| Jason Brown, Ph.D. | Director |
| Holli A. Carlson | Executive |
| Stephen D. Collins, M.D., Ph.D. | Director, Executive |
| Rajeev Dadoo, Ph.D. | Director |
| Luke Evnin, Ph.D. | Director |
| Corey Goodman, Ph.D. | Director |
| Elaine V. Jones, Ph.D. | Director |
| Heath Lukatch, Ph.D. | Director |
| Phillip F. Morgan, Ph.D. | Director |
| Christine Siu | Director |
| Michael Venuti, Ph.D | Executive |
| Todd Verdoorn, Ph.D. | Executive |
| Stephen P. Wanaski | Executive |
| Stephen P. Wanaski, Ph.D. | Executive |
| Brian B. Williams | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8750 W. Bryn Mawr Avenue Suite 440
Chicago, IL, 60631
Chicago, IL, 60631